These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1783325)

  • 81. Acid-soluble sulfhydryl compounds in L-cells during various conditions of growth.
    Sparkes BG; Walker IG
    Can J Biochem; 1966 Aug; 44(8):1159-69. PubMed ID: 4226178
    [No Abstract]   [Full Text] [Related]  

  • 82. [Intracellular effect of hydroxyalkenals on animal tumors (author's transl)].
    Khoschsorur G; Schaur RJ; Schauenstein E; Tillian HM; Reiter M
    Z Naturforsch C Biosci; 1981; 36(7-8):572-8. PubMed ID: 7281898
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Cytotoxicity of cysteine in culture media.
    Nishiuch Y; Sasaki M; Nakayasu M; Oikawa A
    In Vitro; 1976 Sep; 12(9):635-8. PubMed ID: 1034617
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Metabolic control analysis aimed at the ribose synthesis pathways of tumor cells: a new strategy for antitumor drug development.
    Boren J; Montoya AR; de Atauri P; Comin-Anduix B; Cortes A; Centelles JJ; Frederiks WM; Van Noorden CJ; Cascante M
    Mol Biol Rep; 2002; 29(1-2):7-12. PubMed ID: 12241078
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Anticatalase action in vitro and in vivo of cysteine, tyrosine and some related compounds in relation to the anticatalase activity of tumors].
    Ceriotti G; Spandrio L; Agradi A
    Tumori; 1965; 51(6):433-9. PubMed ID: 5880294
    [No Abstract]   [Full Text] [Related]  

  • 86. Cysteine Supplementation Mitigates the Toxicity Associated with Antitumor Therapy of Ehrlich's Ascites Fluid Adsorbed over Protein A Containing
    Verma AS; Singh A; Mallick P; Dwivedi PD
    J Pharm Bioallied Sci; 2019; 11(1):23-32. PubMed ID: 30906136
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Correlation between the radiobiological oxygen constant, K, and the non-protein sulphydryl content of mammalian cells.
    Cullen BM; Michalowski A; Walker HC; Révész L
    Int J Radiat Biol Relat Stud Phys Chem Med; 1980 Nov; 38(5):525-35. PubMed ID: 6969700
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Therapeutic effects of cysteine adducts of alpha, beta-unsaturated aldehydes on Ehrlich ascites tumor of mice. II.
    Tillian HM; Schauenstein E; Esterbauer H
    Eur J Cancer (1965); 1978 May; 14(5):533-6. PubMed ID: 648567
    [No Abstract]   [Full Text] [Related]  

  • 89. Formation and properties of reactive aldehydes.
    Schauenstein E; Esterbauer H
    Ciba Found Symp; 1978; (67):225-44. PubMed ID: 159812
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Selective modulation of non-protein sulfhydryl levels in Ehrlich ascites tumor bearing mice.
    Włodek LB; Wróbel M
    Neoplasma; 1996; 43(4):259-63. PubMed ID: 8931751
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The inhibitory effect of L-cysteine and its derivatives on glycolysis in Ehrlich ascites tumour cells.
    Kedryna T; Gumińska M; Marchut E
    Biochim Biophys Acta; 1983 Aug; 763(1):64-71. PubMed ID: 6871258
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Selective effect of 2-(polyhydroxyalkyl)-thiazolidine-4-carboxylic acids on nonprotein sulfhydryl groups in tumor bearing mice.
    Włodek L; Wróbel M; Czubak J
    Gen Pharmacol; 1996 Dec; 27(8):1373-6. PubMed ID: 9304409
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effects of creatine and beta-guanidinopropionic acid on the growth of Ehrlich ascites tumor cells: i.p. injection and culture study.
    Ohira Y; Inoue N
    Biochim Biophys Acta; 1995 Apr; 1243(3):367-72. PubMed ID: 7727511
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Growth-promoting action of L-cysteine and its related compounds on Ehrlich ascites tumor cells in vitro].
    Takamura S; Yoshida J; Suzuki S
    Nihon Yakurigaku Zasshi; 1991 Dec; 98(6):443-8. PubMed ID: 1783325
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.